Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-02-27 20:08 | 2015-02-25 | RDUS | N/A | BIOTECH GROWTH N V | 10% owner | Other | BUY | $45.74 | 35,000 | $1,600,851 | 3,647,140 | +1.0% |
| 2015-02-28 01:21 | 2015-02-25 | BK | Bank of New York Mellon Corp | GARDEN EDWARD P | Director | State Commercial Banks | BUY | $39.78 | 784,769 | $31,220,073 | 29,955,408 | +2.7% |
| 2015-02-28 00:09 | 2015-02-25 | N/A | Ares Real Estate Income Trust Inc. | JOHNSON JEFFREY L | Officer - Chief Executive Officer | Real Estate Investment Trusts | BUY | $7.18 | 153,203 | $1,100,000 | 325,506 | +88.9% |
| 2015-02-28 00:18 | 2015-02-26 | AXP | AMERICAN EXPRESS CO | CAMPBELL JEFFREY C | Officer - EVP, Chief Financial Officer | Finance Services | BUY | $83.21 | 25,000 | $2,080,250 | 25,000 | +100.0% |
| 2015-02-28 03:21 | 2015-02-25 | TROV | Cardiff Oncology, Inc. | BRIDGER MANAGEMENT, LLC | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $5.36 | 263,286 | $1,411,345 | 2,850,587 | +10.2% |
| 2015-02-28 01:23 | 2015-02-25 | MDLZ | Mondelez International, Inc. | PELTZ NELSON | Director | Food and Kindred Products | BUY | $36.94 | 270,871 | $10,006,760 | 47,479,280 | +0.6% |
| 2015-02-27 21:01 | 2015-02-25 | S | N/A | CLAURE RAUL MARCELO | Officer - President & CEO | Other | BUY | $4.92 | 5,080,000 | $25,006,808 | 7,882,330 | +181.3% |
| 2015-02-27 05:47 | 2015-02-24 | BLBD | Blue Bird Corp | Coliseum Capital Management, LLC | Director, 10% owner | Truck & Bus Bodies | BUY | $10.00 | 2,500,000 | $25,000,000 | 2,500,000 | +100.0% |
| 2015-02-27 00:06 | 2015-02-24 | NHF | NEXPOINT DIVERSIFIED REAL ESTATE TRUST | DONDERO JAMES D | Other | Real Estate Investment Trusts | BUY | $11.54 | 100,867 | $1,164,030 | 4,827,335 | +2.1% |
| 2015-02-27 03:12 | 2015-02-24 | SGEN | N/A | BAKER FELIX | Director, 10% owner | Other | BUY | $33.92 | 281,115 | $9,536,236 | 24,274,259 | +1.2% |
| 2015-02-26 04:36 | 2015-02-23 | ITEK | ROCKET PHARMACEUTICALS, INC. | Pitango Venture Capital Principals Fund IV, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $6.00 | 212,375 | $1,274,250 | 1,292,584 | +19.7% |
| 2015-02-26 02:12 | 2015-02-23 | ITEK | ROCKET PHARMACEUTICALS, INC. | Kantesaria Devang | 10% owner | Pharmaceutical Preparations | BUY | $6.00 | 814,166 | $4,884,996 | 3,243,709 | +33.5% |
| 2015-02-26 02:11 | 2015-02-23 | ITEK | ROCKET PHARMACEUTICALS, INC. | DEVON PARK BIOVENTURES LP | 10% owner | Pharmaceutical Preparations | BUY | $6.00 | 814,166 | $4,884,996 | 3,243,709 | +33.5% |
| 2015-02-26 02:10 | 2015-02-23 | ITEK | ROCKET PHARMACEUTICALS, INC. | MedImmune Ventures, Inc. | 10% owner | Pharmaceutical Preparations | BUY | $6.00 | 416,667 | $2,500,002 | 1,917,906 | +27.8% |
| 2015-02-25 23:20 | 2015-02-23 | ARMK | Aramark | BARR DAVID | Director | Retail-Eating Places | BUY | $29.88 | 7,364,810 | $220,060,523 | 19,731,146 | +59.6% |
| 2015-02-26 01:08 | 2015-02-23 | DD | EIDP, Inc. | BREEN EDWARD D | Director | Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) | BUY | $77.39 | 13,000 | $1,006,090 | 13,000 | +100.0% |
| 2015-02-26 02:16 | 2015-02-23 | ITEK | ROCKET PHARMACEUTICALS, INC. | CARE CAPITAL II LLC | 10% owner | Pharmaceutical Preparations | BUY | $6.00 | 603,832 | $3,622,992 | 2,277,139 | +36.1% |
| 2015-02-26 02:19 | 2015-02-23 | ITEK | ROCKET PHARMACEUTICALS, INC. | KARABELAS ARGERIS N | Director, 10% owner | Pharmaceutical Preparations | BUY | $6.00 | 603,832 | $3,622,992 | 2,277,139 | +36.1% |
| 2015-02-26 02:15 | 2015-02-23 | ITEK | ROCKET PHARMACEUTICALS, INC. | RHO VENTURES IV QP LP | 10% owner | Pharmaceutical Preparations | BUY | $6.00 | 958,226 | $5,749,356 | 2,870,584 | +50.1% |
| 2015-02-24 22:36 | 2015-01-02 | FAFA | N/A | Chen Huangchen | Director, Officer, 10% owner - CEO and President | Other | BUY | $1.00 | 81,680,000 | $81,680,000 | 81,680,000 | +100.0% |
| 2015-02-25 00:40 | 2015-02-20 | D | DOMINION ENERGY, INC | Kington Mark J | Director | Electric Services | BUY | $73.67 | 30,000 | $2,210,241 | 38,366 | +358.6% |
| 2015-02-25 05:43 | 2015-02-24 | TRUE | TrueCar, Inc. | Painter Scott | Director, Officer - CEO & Chairman of the Board | Services-Computer Programming, Data Processing, Etc. | BUY | $17.53 | 70,000 | $1,227,429 | 1,884,563 | +3.9% |
| 2015-02-25 00:02 | 2015-02-23 | XRM | N/A | TOCQUEVILLE ASSET MANAGEMENT L.P. | 10% owner | Other | BUY | $15.35 | 93,800 | $1,439,971 | 1,583,158 | +6.3% |
| 2015-02-25 00:07 | 2015-02-20 | NS | N/A | GREEHEY WILLIAM E | Director | Other | BUY | $61.09 | 74,460 | $4,548,397 | 2,745,826 | +2.8% |
| 2015-02-23 15:36 | 2015-02-19 | AJX | Rithm Property Trust Inc. | Schaub Russell | Director, Officer - President | Real Estate Investment Trusts | BUY | $14.25 | 72,000 | $1,026,000 | 534,000 | +15.6% |
| 2015-02-24 05:46 | 2015-02-19 | BLPH | N/A | Holt Matthew S. | Director, 10% owner | Other | BUY | $12.00 | 1,070,166 | $12,841,992 | 4,859,885 | +28.2% |
| 2015-02-24 05:41 | 2015-02-19 | BLPH | N/A | Luehring Jens | Director, 10% owner | Other | BUY | $12.00 | 358,916 | $4,306,992 | 1,629,804 | +28.2% |
| 2015-02-24 05:47 | 2015-02-19 | BLPH | N/A | Weinstein Adam | Director, 10% owner | Other | BUY | $12.00 | 1,070,166 | $12,841,992 | 4,859,885 | +28.2% |
| 2015-02-24 05:41 | 2015-02-19 | BLPH | N/A | Linde North America, Inc. | 10% owner | Other | BUY | $12.00 | 358,916 | $4,306,992 | 1,629,804 | +28.2% |
| 2015-02-24 01:08 | 2015-02-19 | HCOM | N/A | Twin Haven Capital Partners, L.L.C. | 10% owner | Other | BUY | $26.29 | 50,000 | $1,314,520 | 301,400 | +19.9% |
| 2015-02-24 01:33 | 2015-02-19 | EYEG | KIORA PHARMACEUTICALS INC | IPSA (INNOVEN PARTENAIRES S.A.) | 10% owner | Pharmaceutical Preparations | BUY | $6.00 | 366,667 | $2,200,002 | 1,460,479 | +33.5% |
| 2015-02-24 05:47 | 2015-02-19 | BLPH | N/A | NELSEN ROBERT | Director, 10% owner | Other | BUY | $12.00 | 212,666 | $2,551,992 | 965,660 | +28.2% |
| 2015-02-24 05:48 | 2015-02-19 | BLPH | N/A | ARCH VENTURE FUND VI LP | 10% owner | Other | BUY | $12.00 | 212,666 | $2,551,992 | 965,660 | +28.2% |
| 2015-02-23 14:00 | 2015-02-19 | MDGN | N/A | BARER SOL J | Director | Other | BUY | $7.44 | 150,000 | $1,115,505 | 357,000 | +72.5% |
| 2015-02-24 04:00 | 2015-02-19 | MDLZ | Mondelez International, Inc. | PELTZ NELSON | Director | Food and Kindred Products | BUY | $36.98 | 915,000 | $33,832,583 | 47,208,409 | +2.0% |
| 2015-02-23 15:38 | 2015-02-19 | AJX | Rithm Property Trust Inc. | MENDELSOHN LAWRENCE | Director, Officer - Chief Executive Officer | Real Estate Investment Trusts | BUY | $14.25 | 80,000 | $1,140,000 | 274,667 | +41.1% |
| 2015-02-24 04:49 | 2015-02-19 | AJX | Rithm Property Trust Inc. | Flexpoint Great Ajax Holdings LLC | 10% owner | Real Estate Investment Trusts | BUY | $14.25 | 80,000 | $1,140,000 | 1,917,500 | +4.4% |
| 2015-02-24 05:47 | 2015-02-19 | BLPH | N/A | New Mountain Investments II, LLC | 10% owner | Other | BUY | $12.00 | 1,070,166 | $12,841,992 | 4,859,885 | +28.2% |
| 2015-02-20 18:13 | 2015-02-19 | GE | GENERAL ELECTRIC CO | Beattie William G | Director | Electronic & Other Electrical Equipment (No Computer Equip) | BUY | $25.00 | 400,000 | $10,000,000 | 800,000 | +100.0% |
| 2015-02-21 00:02 | 2015-02-18 | ADXS | Ayala Pharmaceuticals Inc. | ADAGE CAPITAL PARTNERS GP LLC | 10% owner | Pharmaceutical Preparations | BUY | $7.50 | 684,762 | $5,135,715 | 5,139,366 | +15.4% |
| 2015-02-19 16:23 | 2015-02-18 | GE | GENERAL ELECTRIC CO | Beattie William G | Director | Electronic & Other Electrical Equipment (No Computer Equip) | BUY | $25.24 | 400,000 | $10,096,000 | 400,000 | +100.0% |
| 2015-02-19 16:44 | 2015-02-18 | APD | Air Products and Chemicals Inc. | Ghasemi Seifi | Officer - Chairman, Pres. and CEO | Industrial Inorganic Chemicals | BUY | $153.27 | 27,000 | $4,138,406 | 169,171 | +19.0% |
| 2015-02-20 00:20 | 2015-02-19 | MDAS | N/A | WISE R HALSEY | Director, Officer - Chairman and CEO | Other | BUY | $18.15 | 110,300 | $2,001,945 | 125,429 | +729.1% |
| 2015-02-20 03:13 | 2015-02-18 | NVTA | N/A | Flynn James E | 10% owner, Other | Other | BUY | $16.00 | 175,000 | $2,800,000 | 48,388 | +100.0% |
| 2015-02-19 02:17 | 2015-02-18 | SPB | N/A | HARBINGER GROUP INC. | 10% owner, Other | Other | BUY | $94.05 | 17,067 | $1,605,151 | 31,194,944 | +0.1% |
| 2015-02-19 05:00 | 2015-02-16 | LTRE | N/A | COLLINS MARY C | Director, 10% owner | Other | BUY | $1.85 | 3,300,105 | $6,105,194 | 3,768,479 | +704.6% |
| 2015-02-19 05:00 | 2015-02-16 | LTRE | N/A | COLLINS DAVID C | Director, Officer, 10% owner - Chairman of the Board and CEO | Other | BUY | $1.85 | 3,300,105 | $6,105,194 | 3,768,479 | +704.6% |
| 2015-02-19 05:52 | 2014-04-03 | SGMO | SANGAMO THERAPEUTICS, INC | RA CAPITAL MANAGEMENT, LLC | Other | Biological Products, (No Diagnostic Substances) | BUY | $14.67 | 1,205,929 | $17,694,596 | 4,822,236 | +33.3% |
| 2015-02-19 05:51 | 2014-03-07 | SGMO | SANGAMO THERAPEUTICS, INC | RA CAPITAL MANAGEMENT, LLC | Other | Biological Products, (No Diagnostic Substances) | BUY | $19.83 | 1,130,387 | $22,410,035 | 4,317,200 | +35.5% |
| 2015-02-19 05:49 | 2014-02-05 | SGMO | SANGAMO THERAPEUTICS, INC | RA CAPITAL MANAGEMENT, LLC | Other | Biological Products, (No Diagnostic Substances) | BUY | $19.78 | 326,195 | $6,451,354 | 3,683,000 | +9.7% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.